Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- befree-2016 importedOn "2016-02-19" NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_assertion wasGeneratedBy ECO_0000203 NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_assertion wasDerivedFrom befree-2016 NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_assertion SIO_000772 21725906 NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_assertion evidence source_evidence_literature NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.